Search Results for: Immunotherapies

October 17, 2019October 17, 2019

Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment.

Melanoma Literature

Publication date: Oct 11, 2019 Encouraging survival was observed in single arm and randomized phase 2 trials of patient-specific dendritic cell vaccines presenting autologous tumor antigens from autologous cancer cells ... Read more

October 3, 2019October 3, 2019

Combination of Two Immunotherapies Brings Advanced Melanoma Survival Rate to 50% for First Time

Melanoma Media

Publication date: Oct 02, 2019 By combining two existing therapies, researchers at the Royal Marsden NHS Foundation Trust in London have found that they have been able to stop or ... Read more

September 21, 2019September 21, 2019

Possible immunotherapies of skin cancers

Melanoma Literature

Publication date: Sep 18, 2019 Skin cancers represent the most common type of malignancy. The incidence rate of melanoma and non-melanoma skin cancer depicts a continuous rise worldwide, which is ... Read more

July 28, 2019July 28, 2019

Immunotherapies for the Treatment of Uveal Melanoma-History and Future.

Melanoma Literature

Publication date: Jul 24, 2019 Uveal melanoma is the most common primary intraocular malignancy among adults. It is, nevertheless, a rare disease, with an incidence of approximately one case per ... Read more

May 2, 2019May 2, 2019

Exploring the Experiences of People Treated With Immunotherapies for Advanced Melanoma and Those Caring for Them: “Real-World” Data.

Melanoma Literature

Publication date: Feb 18, 2019 Recent advances in the development of immunotherapy drugs have resulted in durable responses and improved overall survival for a proportion of patients with advanced melanoma; ... Read more

May 2, 2019May 2, 2019

Exploring the Experiences of People Treated With Immunotherapies for Advanced Melanoma and Those Caring for Them: “Real-World” Data.

Melanoma Literature

January 24, 2019January 24, 2019

Development of a novel class of interleukin-2 immunotherapies for metastatic cancer.

Melanoma Literature

Publication date: Jan 14, 2019 Tumour immunotherapy, and particularly immue checkpoint inhibitors, have resulted in considerable response rates in patients with metastatic cancer. However, most of these approaches are limited ... Read more

November 9, 2018November 9, 2018

Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies.

Melanoma Literature

Publication date: Sep 06, 2018 Immune checkpoint blockade (ICB) and BRAF-targeted therapy have demonstrated substantial clinical efficacy for patients with stage 4 melanoma in clinical trials; however, their impact on ... Read more

September 24, 2018September 24, 2018

Adjunct immunotherapies for tuberculosis.

Tuberculosis Literature

Publication date: May 15, 2012 The continued spread of multidrug-resistant (MDR) tuberculosis and extensively drug-resistant tuberculosis poses a major threat to global tuberculosis control. Treatment is complex and requires longer ... Read more

September 18, 2018September 18, 2018

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

Melanoma News

Publication date: Sep 17, 2018 The co-primary objectives will be to assess the safety and quality of life under treatment.